Clinically, POMT2 deficiency is often associated with a wide range of clinical involvement, ranging from severe muscle–eye–brain disease and Walker–Warburg syndrome to limb–girdle muscular dystrophy without structural brain or ocular involvement. Here, POMT2 is linked to muscular dystrophy-dystroglycanopathy, type A.